MHC Class II Molecules Play a Role in the Selection of Autoreactive Class I-Restricted CD8 T Cells That Are Essential Contributors to Type 1 Diabetes Development in Nonobese Diabetic Mice
- 15 January 2004
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 172 (2) , 871-879
Abstract
Development of autoreactive CD4 T cells contributing to type 1 diabetes (T1D) in both humans and nonobese diabetic (NOD) mice is either promoted or dominantly inhibited by particular MHC class II variants. In addition, it is now clear that when co-expressed with other susceptibility genes, some common MHC class I variants aberrantly mediate autoreactive CD8 T cell responses also essential to T1D development. However, it was unknown whether the development of diabetogenic CD8 T cells could also be dominantly inhibited by particular MHC variants. We addressed this issue by crossing NOD mice transgenically expressing the TCR from the diabetogenic CD8 T cell clone AI4 with NOD stocks congenic for MHC haplotypes that dominantly inhibit T1D. High numbers of functional AI4 T cells only developed in controls homozygously expressing NOD-derived H2g7 molecules. In contrast, heterozygous expression of some MHC haplotypes conferring T1D resistance anergized AI4 T cells through decreased TCR (H2b) or CD8 expression (H2q). Most interestingly, while AI4 T cells exert a class I-restricted effector function, H2nb1 MHC class II molecules can contribute to their negative selection. These findings provide insights to how particular MHC class I and class II variants interactively regulate the development of diabetogenic T cells and the TCR promiscuity of such autoreactive effectors.Keywords
This publication has 41 references indexed in Scilit:
- Negative selection — clearing out the bad apples from the T-cell repertoireNature Reviews Immunology, 2003
- Identification of Children with Early Onset and High Incidence of Anti-islet AutoantibodiesClinical Immunology, 2002
- HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved?Trends in Genetics, 2001
- SELECTION OF THE T CELL REPERTOIREAnnual Review of Immunology, 1999
- A Mechanism for the Major Histocompatibility Complex–linked Resistance to AutoimmunityJournal of Experimental Medicine, 1997
- CD8 T cells from major histocompatibility complex class II‐deficient mice respond vigorously to class II molecules in a primary mixed lymphocyte reactionEuropean Journal of Immunology, 1997
- Mechanisms of tolerance to selfCurrent Opinion in Immunology, 1996
- Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.Journal of Experimental Medicine, 1992
- Mice lacking MHC class II moleculesCell, 1991
- Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A β-chain or normal I-E α-chainNature, 1990